Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-16

Clinical Trial Update: Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease [Phase 2, Phase 3]

View source ↗

Summary

This report updates on a completed Phase 2/3 clinical trial evaluating the initial prescription of ketamine and milnacipran for depression in patients with a pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Milnacipran (milnacipran)

Snippet

Sponsor: University Hospital, Lille | Conditions: Depression | Phase 2, Phase 3 | Status: COMPLETED